Use of Chinese medicine by women with breast cancer: A nationwide cross-sectional study in Taiwan
Introduction
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females worldwide, accounting for 23% of the total cancer cases and 14% of the cancer deaths in 2008.1 Incidence rates of breast cancer are high in most of the developed areas. Although the incidence rates are low in the most part of Asia, breast cancer is currently the most common cancer among women in Asia and is increasing in incidence.2 In Taiwan, breast cancer is also the most common female cancer.3
Use of complementary and alternative medicine (CAM) is increasing among oncology patients in recent decades.4, 5 Previous studies showed that breast cancer patients were more likely to be CAM users compared with other tumor sites.6, 7, 8, 9 The prevalence of CAM among breast cancer patients varies widely, with estimates ranging from 28% to 97%.7, 8, 10, 11, 12, 13, 14, 15, 16, 17, 18 CAM comprises a diverse set of healing philosophies, therapies, and products. Chinese medicine (CM) is one of the most popular types of CAM worldwide. CM continues to play a significant role in the health care systems of many East Asian countries.19, 20, 21, 22, 23, 24, 25, 26 Acupuncture and Chinese herbal medicine are well known and practiced in the West.27, 28, 29, 30 Therefore, a large-scale study to explore the utilization of CM among breast cancer patients is necessary.
Taiwan launched a National Health Insurance (NHI) program since 1995. More than 99% of the 23 million Taiwan citizens and legal residents were enrolled. The range of care covered by NHI includes inpatient and ambulatory care, dental services, traditional Chinese medicine, child delivery services, physical rehabilitation, home care, and chronic mental illness care. More than 92% of providers contracted with NHI. Beneficiaries are free to choose Western medicine (WM) and CM services. The National Health Insurance Research Database (NHIRD) was released for research. In this study, we use NHIRD to explore the prevalence, patterns and costs of CM among breast cancer patients.
Section snippets
Data sources
This retrospective cross-sectional study used registration and claim datasets of NHIRD, including outpatient claims (CN2007 and CM2007), inpatient claims (DD2007) and registry for catastrophic illness patients (HV2007) of the year 2007. Before database construction at the National Health Research Institutes, data that could be used to identify patients or care providers has been scrambled by NHI. The data is then further scrambled before being released to each researcher. Since this study used
Results
A total of 70,012 female breast cancer patients were identified (Fig. 1). Among them, 24,955 (35.6%) patients used CM outpatient services at least once in 2007. Among all CM non-users, 37,737 patients used WM ambulatory services, 232 used inpatient care only and 7088 have no clinical visit.
Discussion
This is the first study to provide precise estimates for the prevalence of CM use among breast cancer patient in an entire population. The principal findings are that a significant portion of breast cancer patients used CM and most CM users also used Western medicine. Chinese herbal medicine was used most frequently. The potential of drug–herb interactions should be concerned. Besides, our results demonstrated that breast cancer patients used CM for non-cancer diseases more than for breast
Conflict of interest
The authors declare no conflict of interest.
Acknowledgments
This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by National Health Research Institutes. The interpretations and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health or National Health Research Institutes.
This work was supported by National Yang-Ming University and Cheng Hsin General Hospital (grant number 100-31
References (37)
- et al.
A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites
Am J Surg
(2000) - et al.
Use of complementary and alternative medicine in cancer patients: a European survey
Ann Oncol
(2005) - et al.
The practice of Chinese medicine in Taiwan
Soc Sci Med
(1996) Traditional healing systems and the ethos of science
Soc Sci Med
(2003)- et al.
Use and expenditure on complementary medicine in England: a population based survey
Complement Ther Med
(2001) - et al.
Agreement between self-reported and health insurance claims on utilization of health care: a population study
J Clin Epidemiol
(2009) - et al.
Insurance covered and non-covered complementary and alternative medicine utilisation among adults in Taiwan
Soc Sci Med
(2008) - et al.
Global cancer statistics
CA Cancer J Clin
(2011) - et al.
Global cancer statistics, 2002
CA Cancer J Clin
(2005) - Bureau of Health Promotion DoH, R.O.C. (Taiwan). 2007 annual report. Taipei: Bureau of Health Promotion, Department of...